TURBO OPTIONSSCHEIN - VIVORYON THERAPEUTICS | Market Closed - Bid/Ask 02:15:40 2024-05-23 am EDT | After market 03:14:02 pm | |||
| 0.81 EUR | +32.79% |
|
1.22 | +50.62% |
| Current month | +8.93% | ||
| 1 month | +125.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VIVORYON THERAPEUTICS N.V.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 0.81 | +32.79% |
| 24-05-22 | 0.61 | -3.17% |
| 24-05-21 | 0.63 | +1.61% |
| 24-05-20 | 0.62 | +10.71% |
| 24-05-17 | 0.56 | -1.75% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 02:15 am EDT
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIVORYON THERAPEUTICS N.V. |
| Issuer | Lang & Schwarz |
| WKN | LX3Y68 |
| ISIN | DE000LX3Y680 |
| Date issued | 2024-03-06 |
| Strike | 0.2 € |
| Maturity | 2024-12-12 (203 Days) |
| Parity | 1 : 1 |
| Emission price | 0.68 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.82 € |
|---|---|
| Lowest since issue | 0.23 € |
| Spread | 0.3 € |
| Spread % | 21.58% |
Company Profile
Vivoryon Therapeutics N.V. specializes in the research and development of therapeutic products for the treatment of Alzheimer disease.
At the end of 2022, the group has a portfolio of a product in phase II clinical development (Varoglutamstat; PQ912) and 2 products in the preclinical development phase.
Sector
-
Consensus: Vivoryon Therapeutics N.V.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
0.821
EUR
Average target price
41.57
EUR
Spread / Average Target
+4,962.93%
- Stock Market
- Certificates
- Certificat
